Clinical Features and Prognosis of 23 Cases of Adult T-Cell Leukemia/Lymphoma in Ningde City, Fujian Province and Efficacy of Antiviral Therapy --a Retrospectively Analysis.
10.19746/j.cnki.issn.1009-2137.2025.02.008
- Author:
Chang-Gui WANG
1
;
Ren-Li CHEN
1
;
Xiao-Lan LAI
1
Author Information
1. Department of Hematology, Ningde Affiliated Hospital of Ningde Normal University, Ningde 352100, Fujian Province, China.
- Publication Type:Journal Article
- Keywords:
adult T-cell leukemia/lymphoma;
clinical manifestations;
prognosis
- MeSH:
Humans;
Retrospective Studies;
Middle Aged;
Leukemia-Lymphoma, Adult T-Cell/diagnosis*;
Male;
Adult;
Female;
Prognosis;
Aged;
Antiviral Agents/therapeutic use*;
Aged, 80 and over;
China
- From:
Journal of Experimental Hematology
2025;33(2):359-364
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the clinical characteristics and prognosis of patients with adult T-cell leukemia/lymphoma (ATLL) in Ningde City, Fujian Province.
METHODS:We retrospectively collected 23 cases diagnosed with adult T-cell leukemia/lymphoma in the Hematology Department of Ningde Hospital Affiliated to Ningde Normal University from 2014 to 2023, the clinical characteristics of patients were summarized and the prognosis was analyzed. The survival of patients treated with chemotherapy alone and chemotherapy combined with antiviral therapy was compared.
RESULTS:All 23 patients were from the coastal endemic area of Fujian (Ningde City), 12 males and 11 females. The median age of onset was 59 (range: 31-84) years old. The clinical types were acute (18 cases) or lymphomatous (5 cases), and no smoldering or chronic type was seen. The most common clinical manifestations were, in order of prevalence, 20 cases of leukocytosis, 19 cases of lymph node enlargement, 13 cases of skin lesions, 13 cases of hypercalcemia. There was an elevation of lactate dehydrogenase (LDH) levels in more than 90% of cases, and β2-microglobulin levels were elevated in 11 cases. Twelve of the 23 patients were treated with chemotherapy (partly in combination with antiviral therapy), one underwent allogeneic hematopoietic stem cell transplantation. The median overall survival of all patients was 2.3(0.2-13) months. Median survival was 3(2-11) months in the chemotherapy combined with antiviral therapy group, while that of the chemotherapy alone group was 2(0.2-13) months.
CONCLUSION:The clinical manifestations of adult T-cell leukemia/lymphoma in Ningde city, Fujian province are characteristic and the prognosis is unfavorable. Antiviral therapy may contribute to an improvement in the prognosis.
